93 related articles for article (PubMed ID: 8652130)
1. Geranylgeraniol restores cell proliferation to lovastatin treated C6 glial cells.
Crick DC; Waechter CJ; Andres DA
SAAS Bull Biochem Biotechnol; 1996; 9():37-42. PubMed ID: 8652130
[TBL] [Abstract][Full Text] [Related]
2. Lovastatin-induced proliferation inhibition and apoptosis in C6 glial cells.
Choi JW; Jung SE
J Pharmacol Exp Ther; 1999 Apr; 289(1):572-9. PubMed ID: 10087052
[TBL] [Abstract][Full Text] [Related]
3. Geranylgeraniol overcomes the block of cell proliferation by lovastatin in C6 glioma cells.
Crick DC; Andres DA; Danesi R; Macchia M; Waechter CJ
J Neurochem; 1998 Jun; 70(6):2397-405. PubMed ID: 9603204
[TBL] [Abstract][Full Text] [Related]
4. Lovastatin inhibits proliferation of rat mesangial cells.
O'Donnell MP; Kasiske BL; Kim Y; Atluru D; Keane WF
J Clin Invest; 1993 Jan; 91(1):83-7. PubMed ID: 8423236
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of cholesterol synthesis by squalene synthase inhibitors does not induce myotoxicity in vitro.
Flint OP; Masters BA; Gregg RE; Durham SK
Toxicol Appl Pharmacol; 1997 Jul; 145(1):91-8. PubMed ID: 9221828
[TBL] [Abstract][Full Text] [Related]
6. Role of RhoA activation in the growth and morphology of a murine prostate tumor cell line.
Ghosh PM; Ghosh-Choudhury N; Moyer ML; Mott GE; Thomas CA; Foster BA; Greenberg NM; Kreisberg JI
Oncogene; 1999 Jul; 18(28):4120-30. PubMed ID: 10435593
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological control of the mevalonate pathway: effect on arterial smooth muscle cell proliferation.
Raiteri M; Arnaboldi L; McGeady P; Gelb MH; Verri D; Tagliabue C; Quarato P; Ferraboschi P; Santaniello E; Paoletti R; Fumagalli R; Corsini A
J Pharmacol Exp Ther; 1997 Jun; 281(3):1144-53. PubMed ID: 9190847
[TBL] [Abstract][Full Text] [Related]
8. Regulation of proliferation and Ras localization in transformed cells by products of mevalonate metabolism.
Cuthbert JA; Lipsky PE
Cancer Res; 1997 Aug; 57(16):3498-505. PubMed ID: 9270019
[TBL] [Abstract][Full Text] [Related]
9. HMG CoA reductase inhibitor-induced myotoxicity: pravastatin and lovastatin inhibit the geranylgeranylation of low-molecular-weight proteins in neonatal rat muscle cell culture.
Flint OP; Masters BA; Gregg RE; Durham SK
Toxicol Appl Pharmacol; 1997 Jul; 145(1):99-110. PubMed ID: 9221829
[TBL] [Abstract][Full Text] [Related]
10. Lovastatin-induced PC-12 cell differentiation is associated with RhoA/RhoA kinase pathway inactivation.
Fernández-Hernando C; Suárez Y; Lasunción MA
Mol Cell Neurosci; 2005 Aug; 29(4):591-602. PubMed ID: 15951198
[TBL] [Abstract][Full Text] [Related]
11. Farnesol is utilized for protein isoprenylation and the biosynthesis of cholesterol in mammalian cells.
Crick DC; Andres DA; Waechter CJ
Biochem Biophys Res Commun; 1995 Jun; 211(2):590-9. PubMed ID: 7794274
[TBL] [Abstract][Full Text] [Related]
12. Lack of isoprenoid products raises ex vivo interleukin-1beta secretion in hyperimmunoglobulinemia D and periodic fever syndrome.
Frenkel J; Rijkers GT; Mandey SH; Buurman SW; Houten SM; Wanders RJ; Waterham HR; Kuis W
Arthritis Rheum; 2002 Oct; 46(10):2794-803. PubMed ID: 12384940
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Ras farnesylation by lovastatin leads to downregulation of proliferation and migration in primary cultured human glioblastoma cells.
Bouterfa HL; Sattelmeyer V; Czub S; Vordermark D; Roosen K; Tonn JC
Anticancer Res; 2000; 20(4):2761-71. PubMed ID: 10953355
[TBL] [Abstract][Full Text] [Related]
14. The mevalonate pathway: importance in mesangial cell biology and glomerular disease.
O'Donnell MP; Kasiske BL; Kim Y; Atluru D; Keane WF
Miner Electrolyte Metab; 1993; 19(3):173-9. PubMed ID: 8232104
[TBL] [Abstract][Full Text] [Related]
15. Geranylgeraniol promotes entry of UT-2 cells into the cell cycle in the absence of mevalonate.
Crick DC; Andres DA; Waechter CJ
Exp Cell Res; 1997 Mar; 231(2):302-7. PubMed ID: 9087171
[TBL] [Abstract][Full Text] [Related]
16. Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro.
Fisher JE; Rogers MJ; Halasy JM; Luckman SP; Hughes DE; Masarachia PJ; Wesolowski G; Russell RG; Rodan GA; Reszka AA
Proc Natl Acad Sci U S A; 1999 Jan; 96(1):133-8. PubMed ID: 9874784
[TBL] [Abstract][Full Text] [Related]
17. Farnesol and geranylgeraniol: prevention and reversion of lovastatin-induced effects in NIH3T3 cells.
Ownby SE; Hohl RJ
Lipids; 2002 Feb; 37(2):185-92. PubMed ID: 11908910
[TBL] [Abstract][Full Text] [Related]
18. The bisphosphonate incadronate (YM175) causes apoptosis of human myeloma cells in vitro by inhibiting the mevalonate pathway.
Shipman CM; Croucher PI; Russell RG; Helfrich MH; Rogers MJ
Cancer Res; 1998 Dec; 58(23):5294-7. PubMed ID: 9850051
[TBL] [Abstract][Full Text] [Related]
19. Utilization of geranylgeraniol for protein isoprenylation in C6 glial cells.
Crick DC; Waechter CJ; Andres DA
Biochem Biophys Res Commun; 1994 Nov; 205(1):955-61. PubMed ID: 7999138
[TBL] [Abstract][Full Text] [Related]
20. Relationship between mevalonate pathway and arterial myocyte proliferation: in vitro studies with inhibitors of HMG-CoA reductase.
Corsini A; Mazzotti M; Raiteri M; Soma MR; Gabbiani G; Fumagalli R; Paoletti R
Atherosclerosis; 1993 Jun; 101(1):117-25. PubMed ID: 8216498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
